Products
EVA™ is the device that offers a safe, effective, comfortable and non-ablative solution for the…
READ MORE4PLUS ™ is designed and studied for the treatment of the main pathologies and imperfections…
READ MOREIFL ™ is revolutionary for speed and comfort, which allows you to perform effective treatments…
READ MOREBODYKA™ PLUS is the non-invasive high-tech alternative to surgical liposuction, to effectively and specifically treat…
READ MOREBODIKA™ is a biotechnological device designed specifically to effectively, comfortably and with complete safely, treat…
READ MOREExhibitions & Events
-
January 22, 2020IMCAS 2020 -
January 20, 2020Aigef 2020Aigef 2020: This year we will be in Rome at the monumental complex s. Spirit in Sassia to share the latest news about vaginal-vaginal aesthetic surgery! We are waiting for you on 24 and 25 January at stand nr. 6.
-
November 27, 20193th National Congress SIGITE – SIMFrom 4th to 6th December we will be at the 3th National Congress SIGITE – SIM in Milan. Focus of the event: the woman’s health in menopause.
-
November 22, 2019Sesta giornata paveseIt ends a month of November full of great events! We are waiting for you on 29 November at Sesta Giornata Pavese di Psiconeuroendocrinologia al Femminile O at the Aula Maugeri, Foundation Salvatore Maugeri di Pavia.
DOTT. FILIPPO MURINA
Responsible of Vulvar Patology Service at the hospital V.Buzzi – University of Milano
Research & Development
INNOVATION AND QUALITY, THE BEAUTY OF SUCCESS
As a leading company in the sector, Novavision Group has always attached great importance to improvement and innovation.
An endless wish to update, a state-of-the-art technological approach, a drive towards excellence and achieving goals – these are the company’s characterising features, which gave it the opportunity to consolidate its position on the national and international scene. This said, it is of the utmost importance to keep working, to improve existing technologies and design brand-new ones, promoting constant investments in Research & Development.
LEARN MORE